Article Details

Aytu stock falls amid suspending clinical programs to save costs | Seeking Alpha

Retrieved on: 2022-10-13 16:42:00

Tags for this article:

Click the tags to see associated articles and topics

Aytu stock falls amid suspending clinical programs to save costs | Seeking Alpha. View article details on hiswai:

Excerpt

Aytu BioPharma (AYTU) stock fell ~5% on Oct. 13 after the company said it was indefinitely suspending certain clinical development programs which ...

Article found on: seekingalpha.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up